SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-22-032209
Filing Date
2022-12-19
Accepted
2022-12-19 16:09:42
Documents
18
Period of Report
2022-12-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sgmo-20221215.htm   iXBRL 8-K 50198
2 EX-3.1 sgmo-20221219xxex31fifth.htm EX-3.1 79700
6 GRAPHIC sgmo-20221219xxex31fifth001.jpg GRAPHIC 1181309
7 GRAPHIC sgmo-20221219xxex31fifth002.jpg GRAPHIC 1300070
8 GRAPHIC sgmo-20221219xxex31fifth003.jpg GRAPHIC 1144752
9 GRAPHIC sgmo-20221219xxex31fifth004.jpg GRAPHIC 1089716
10 GRAPHIC sgmo-20221219xxex31fifth005.jpg GRAPHIC 617746
  Complete submission text file 0001628280-22-032209.txt   7646384

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sgmo-20221215.xsd EX-101.SCH 1941
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sgmo-20221215_lab.xml EX-101.LAB 25133
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sgmo-20221215_pre.xml EX-101.PRE 13080
12 EXTRACTED XBRL INSTANCE DOCUMENT sgmo-20221215_htm.xml XML 11804
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 221471165
SIC: 2836 Biological Products, (No Diagnostic Substances)